[1] S. M. Melana, L. Nepomnaschy, J. Hasa, A. Djougarian, J. F. Holland, and B. G. Pogo, “Detection of Human Mammary Tumor Virus Proteins in Human Breast Cancer Cells,” Journal of Virological Methods, Vol. 163, No. 1, pp. 157–161, 2010. DOI: 10.1016/j.jviromet.2009.09.012.
[2] P. Sharma, P. Sharan, and P. Deshmukh, “Photonic Crystal Sensor for Analysis and Detection of Cancer Cells,” in International Conference on Pervasive Computing (ICPC), pp. 1–5, IEEE, Jan. 2015.
[3] M. L. Leung, A. Davis, R. Gao, A. Casasent, Y. Wang, E. Sei, et al., “Single-Cell DNA Sequencing Reveals a Late-Dissemination Model in Metastatic Colorectal Cancer,” Genome Research, Vol. 27, No. 8, pp. 1287–1299, 2017. DOI: 10.1101/gr.209973.116.
[4] M. L. Shehab, Q. Abualigah, M. Shambour, M. A. Abu-Hashem, M. K. Y. Shambour, A. Alsalibi, and A. H. Gandomi, “Machine Learning in Medical Applications: A Review of State-of-the-Art Methods,” Computers in Biology and Medicine, Vol. 145, Art. 105458, 2022. DOI: 10.1016/j.compbiomed.2022.105458.
[5] G. Kumar and H. Alqahtani, “Deep Learning-Based Cancer Detection—Recent Developments, Trend and Challenges,” CMES—Computer Modeling in Engineering & Sciences, Vol. 130, No. 3, 2022. DOI: 10.32604/cmes.2022.019989.
[6] K. D. Shree and S. Logeswari, “ODRNN: Optimized Deep Recurrent Neural Networks for Automatic Detection of Leukaemia,” Signal, Image and Video Processing, pp. 1–17, 2024. DOI: 10.1007/s11760-024-03010-5.
[7] M. Shahin, F. Chen, F. A. Hosseinzadeh, and M. Maghanaki, “Deploying Deep Convolutional Neural Network to the Battle Against Cancer: Towards Flexible Healthcare Systems,” Informatics in Medicine Unlocked, Vol. 47, Art. 101494, 2024. DOI:10.1016/j.imu.2024.101494.
[8] U. Saeed, K. Kumar, M. A. Khuhro, A. A. Laghari, A. A. Shaikh, and A. Rai, “DeepLeukNet—A CNN-Based Microscopy Adaptation Model for Acute Lymphoblastic Leukemia Classification,” Multimedia Tools and Applications, Vol. 83, No. 7, pp. 21019–21043, 2024. DOI: 10.1007/s11042-023-16123-8.
[9] A. Batool and Y. C. Byun, “Lightweight EfficientNet-B3 Model Based on Depthwise Separable Convolutions for Enhancing Classification of Leukemia White Blood Cell Images,” IEEE Access, 2023. DOI: 10.1109/ACCESS.2023.3241568.
[10] H. Xu, J. Jia, H. H. Jeong, and Z. Zhao, “Deep Learning for Detecting and Elucidating Human T-Cell Leukemia Virus Type 1 Integration in the Human Genome,” Patterns, Vol. 4, No. 2, 2023. DOI: 10.1016/j.patter.2023.100742.
[11] S. A. Patel, “Functional Genomic Approaches in Acute Myeloid Leukemia: Insights Into Disease Models and the Therapeutic Potential of Reprogramming,” Cancer Letters, Vol. 533, Art. DOI: 215579, 2022. DOI: 10.1016/j.canlet.2022.215579.
[12] S. A. Patel, D. Dalela, A. C. Fan, M. R. Lloyd, and T. Y. Zhang, “Niche-Directed Therapy in Acute Myeloid Leukemia: Optimization of Stem Cell Competition for Niche Occupancy,” Leukemia & Lymphoma, Vol. 63, No. 1, pp. 10–18, 2022. DOI: 10.1080/10428194.2022.2029247.
[13] A. Damnernsawad, D. Bottomly, S. E. Kurtz, C. A. Eide, S. K. McWeeney, J. W. Tyner, and T. Nechiporuk, “A Genome-Wide CRISPR Screen Identifies Regulators of MAPK and mTOR Pathways That Mediate Resistance to Sorafenib in Acute Myeloid Leukemia,” Haematologica, Vol. 107, No. 1, p. 77, 2022. DOI: 10.1186/s13045-022-01250-8.
[14] I. A. Basurto-Hurtado, M. Cruz-Albarran, M. Toledano-Ayala, M. A. Ibarra-Manzano, L. A. Morales-Hernandez, and C. A. Perez-Ramirez, “Diagnostic Strategies for Breast Cancer Detection: From Image Generation to Classification Using Artificial Intelligence Algorithms,” Cancers, Vol. 14, No. 14, Art. 3442, 2022. DOI: 10.3390/cancers14143442.
[15] R. L. Siegel, K. D. Miller, H. E. Fuchs, and A. Jemal, “Cancer Statistics,” CA: A Cancer Journal for Clinicians, Vol. 72, No. 1, 2022. DOI: 10.3322/caac.21708.
[16] A. Slomski, “Colonoscopy Did Not Reduce Cancer Deaths in Trial,” JAMA, Vol. 328, No. 20, pp. 2003–2004, 2022. DOI: 10.1001/jama.2022.20402.
[17] M. H. Antoni, P. I. Moreno, and F. J. Penedo, “Stress Management Interventions to Facilitate Psychological and Physiological Adaptation and Optimal Health Outcomes in Cancer Patients and Survivors,” Annual Review of Psychology, Vol. 74, pp. 423–455, 2023. DOI: 10.1146/annurev-psych-032420-031042.
[18] X. Zheng, X. Wang, Y. He, and H. Ge, “Systematic Analysis of Expression Profiles of HMGB Family Members for Prognostic Application in Non-Small Cell Lung Cancer,” Frontiers in Molecular Biosciences, Vol. 9, Art. 844618, 2022. DOI: 10.3389/fmolb.2022.844618.
[19] M. E. Francis, P. Mohindra, and K. Mooney-Doyle, “Exploring Dyad-Based Communication During Cancer: A Pilot Study,” Cancer Nursing, Vol. 46, No. 6, pp. E384–E393, 2023. DOI: 10.1177/08445621221144594
[20] K. R. Haase, S. Sattar, S. Dhillon, H. M. Kilgour, J. Pesut, D. Howell, and J. L. Oliffe, “A Survey of Older Adults’ Self-Managing Cancer,” Current Oncology, Vol. 29, No. 11, pp. 8019–DOI: 8030, 2022. 10.3390/curroncol291108019.
[21] P. Dixon, R. M. Martin, and S. Harrison, “Using Mendelian Randomization to Model the Causal Effect of Cancer on Health Economic Outcomes and to Simulate the Cost-Effectiveness of Anti-Cancer Interventions,” medRxiv, 2023. DOI: 10.1101/2023.05.03.23289471.
[22] H. Patadia, A. Priyadarshini, and A. Gangawane, “Integrated Proteomic, Transcriptomic, and Genomic Analysis Identifies Fibrinogen Beta and Fibrinogen Gamma as Key Modulators of Breast Cancer Progression and Metastasis,” Biomedical and Biotechnology Research Journal (BBRJ), Vol. 6, No. 2, pp. 266–277, 2022. DOI: 10.2147/BBRJ.S353435.
[23] M. A. Berbís, D. S. McClintock, A. Bychkov, J. Van der Laak, L. Pantanowitz, J. Lennerz, and J. Shen, “Computational Pathology in 2030: A Delphi Study Forecasting the Role of AI in Pathology Within the Next Decade,” EBioMedicine, Vol. 88, 2023. DOI: 10.1016/j.ebiom.2023.104863.
[24] M. Momenzadeh, M. Sehhati, and H. Rabbani, “A Novel Feature Selection Method for Microarray Data Classification Based on Hidden Markov Model,” Journal of Biomedical Informatics, Vol. 95, Art. 103213, 2019. DOI: 10.1016/j.jbi.2019.103213.
[25] A. Dempster, D. F. Schmidt, and G. I. Webb, “MINIH: A Very Fast (Almost) Deterministic Transform for Time Series Classification,” in Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining, pp. 248–257, Aug. 2021. DOI: 10.1145/3447548.3467201.
[26] J. Wang, “An interpretable integrated machine learning framework for genomic data,” Journal of Biomedical Informatics, 2025.
[27] H. Salehinejad, Y. Wang, Y. Yu, T. Jin, and S. Valaee, “S-ROCKET: Selective Random Convolution Kernels for Time Series Classification,” arXiv preprint arXiv:2203.03445, 2022. DOI: 10.48550/arXiv.2203.03445.
[28] N. Papaioannou, G. Myllis, A. Tsimpiris, and V. Vrana, “The Role of Mutual Information Estimator Choice in Feature Selection: An Empirical Study on mRMR,” Information, Vol. 16, Art. 724, 2025. DOI: 10.3390/info16090724.
[29] B. I. Grisci, B. C. Feltes, and M. Dorn, “Neuroevolution as a Tool for Microarray Gene Expression Pattern Identification in Cancer Research,” Journal of Biomedical Informatics, Vol. 89, pp. 122–133, 2019. DOI: 10.1016/j.jbi.2018.11.013.
[30] S. Z. Aftabi, A. Ahmadi, and S. Farzi, “Fraud Detection in Financial Statements Using Data Mining and GAN Models,” Expert Systems with Applications, Vol. 227, Art. 120144, 2023. DOI: 10.1016/j.eswa.2022.120144.
[31] M. A. Hossain, A. M. Islam, S. Islam, S. Shatabda, and A. Ahmed, “Symptom-Based Explainable Artificial Intelligence Model for Leukemia Detection,” IEEE Access, Vol. 10, pp. 57283–57298, 2022. DOI: 10.1109/ACCESS.2022.3178440.
[32] P. K. Das and S. Meher, “An Efficient Deep Convolutional Neural Network-Based Detection and Classification of Acute Lymphoblastic Leukemia,” Expert Systems with Applications, Vol. 183, Art. 115311, 2021. DOI: 10.1016/j.eswa.2021.115311.
[33] M. Jawahar, H. Sharen, and A. H. Gandomi, “ALNett: A Cluster Layer Deep Convolutional Neural Network for Acute Lymphoblastic Leukemia Classification,” Computers in Biology and Medicine, Vol. 148, Art. 105894, 2022. DOI: 10.1016/j.compbiomed.2022.105894.
